Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
CMAJ Specialty Spotlight: Diagnostic molecular biology

Gone FISHin' for genes

Doug J. Demetrick
CMAJ November 02, 1999 161 (9) 1138;
Doug J. Demetrick
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Responses
  • Metrics
  • PDF
Loading

Technology: Fluorescence in situ hybridization (FISH)

Use: FISII allows direct visualization of individual chromosomes or genes in tissue and cell specimens and is used as a cancer diagnostic tool to identify large DNA alterations.

History: To a cytogeneticist or anatomic pathologist, "going FISHin'" has quite a different meaning than the usual relaxing pastime. FISII was developed in 1986 as an offshoot of in situ hybridization.[1, 2] In the original technique, a nucleic acid probe (single strand of DNA or RNA) was labelled with a radioisotope and allowed to bind to its complementary strand in a tissue or cell specimen. The location of the signal could be observed by autoradiography on high-resolution photographic film. FISH was developed to identify, by fluorescence, cells containing a genetic target from a complex mixture. The probe is labelled with a fluorescent dye that hybridizes to a DNA target and can be directly seen with fluorescent microscopy. Major advantages of FISII are the brightness of the signal seen and the narrow wavelength of light that each fluor emits, allowing multiple fluors to be easily distinguished in the same sample. Furthermore, the fluor is confined to the binding site, unlike other dyes which precipitate around the binding site. This precise localization allows mapping of the fluorescent signal to subcellular levels and can even be used to determine the location of specific genes (Figure). This technique can also allow quantitation of the number of targets (or genes) in a specific interphase cell nucleus (Figure inset) and may eventually be useful as an indicator of biologic potential in a tumour such as a breast carcinoma. The simultaneous use of numerous fluorescent probes, each emitting light at a different wavelength, makes FISH one of the most aesthetically pleasing of all medical diagnostic tests.[3, 4]

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Figure. Visualization of human genes using FISH. A DNA probe for single-copy gene is labelled with fluorescent dye and allowed to bind to normal metaphase chromosome spread (stained blue-white). Interphase nucleus also shows 2 copies of target gene. Inset: Amplification of genes in breast cancer cells. Green signals indicate normal number of copies of RB1 gene, and red signals indicate excessive number of copies of CCND1 (Cyclin D1) gene.

Promise: With its ability to identify single genes FISH can be used in uncultured interphase cells, providing a much faster and cheaper method of chromosome identification than band karyotyping, which depends on living cell cultures. Current clinical uses of FISH involve rapid chromosome counting (e.g., to diagnose Down's syndrome) in interphase cells and identification of chromosomal rearrangements such as translocations in cancer specimens.

Problems: FISH requires significant technical expertise to obtain consistent results and a good fluorescent microscope; a digital camera is highly recommended.

Prospects: More recent applications of FISH include comparative genomic hybridization3 and spectral karyotype analysis.4 In these applications FISH may be more sensitive than conventional karyotyping for detecting chromosomal abnormalities in cancer specimens. Enhancements to FISH occur frequently.[5, 6] Future diagnostic applications may involve quantitation of genes such as c-erbB-2 as predictive or prognostic indicators in cancer specimens. Furthermore, digital image capture and quantitation is ideal for fluorescent images and has the potential to be more sensitive than other visualization techniques. Such imaging technology is also amenable to automated analysis, thus offering the prospect of lower costs, shorter turnaround times and greater productivity than manual methods.

New technologies are emerging such as laser-capture microdissection, with which specific cells can be dissected from a tumour specimen, and array chips, in which hundreds or thousands of molecular parameters may be analysed from a single specimen. These technologies may eventually offer quantitation of a wider panel of specific genes from clinical samples and will likely decrease some of the diagnostic applications of FISH.

Competing interests: None declared.

References

  1. 1.↵
    Cremer T, Landegent J, Bruckner A, Scholl HP, Schardin M, Hager HD, et al. Detection of chromosome aberrations in the human interphase nucleus by visualization of specific target DNAs with radioactive and non-radioactive in situ hybridization techniques: diagnosis of trisomy 18 with probe L1.84. Hum Genet 1986;74(4):346-52.
    OpenUrlCrossRefPubMed
  2. 2.↵
    Pinkel D, Straume T, Gray JW. Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization. Proc Natl Acad Sci U S A 1986;83(9):2934-8.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, et al. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 1992;258:818-21.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    Schrock E, du Manoir S, Veldman T, Schoell B, Wienberg J, Ferguson-Smith MA, et al. Multicolor spectral karyotyping of human chromosomes. Science 1996;273:494-7.
    OpenUrlAbstract
  5. 5.↵
    Van den Veyver IB, Roa BB. Applied molecular genetic techniques for prenatal diagnosis. Curr Opin Obstet Gynecol 1998;10(2):97-103.
    OpenUrlCrossRefPubMed
  6. 6.↵
    Luke S, Shepelsky M. FISH: recent advances and diagnostic aspects. Cell Vision 1998;5(1):49-53.
    OpenUrlPubMed
PreviousNext
Back to top

In this issue

CMAJ
Vol. 161, Issue 9
2 Nov 1999
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Gone FISHin' for genes
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Gone FISHin' for genes
Doug J. Demetrick
CMAJ Nov 1999, 161 (9) 1138;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Gone FISHin' for genes
Doug J. Demetrick
CMAJ Nov 1999, 161 (9) 1138;
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • References
  • Figures & Tables
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Genetics 101: cytogenetics and FISH
  • The very youngest science
  • Google Scholar

Similar Articles

Collections

  • Topics
    • Genetics

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
  • Accessibiity
  • CMA Civility Standards
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

Powered by HighWire